Sepsis-like cytokine release syndrome after application of tebentafusp in metastasized uveal melanoma

被引：0
|
作者：
Geidel, Glenn [1 ,2 ]
Abeck, Finn [1 ]
Hansen, Inga [1 ]
Koett, Julian [1 ,2 ]
Heidrich, Isabel [1 ,2 ]
Ruenger, Alessandra [1 ,2 ]
Hildebrandt, Lina [1 ]
Gebhardt, Christoffer [1 ,2 ,3 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Univ Skin Canc Ctr Hamburg, Dept Dermatol & Venereol, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Fleur Hiege Ctr Skin Canc Res, Hamburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Dept Dermatol & Venereol, D-20246 Hamburg, Germany
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2024年 / 38卷 / 06期
关键词：
D O I：
10.1111/jdv.19660
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e473 / e475
页数：3
相关论文
共 50 条
  • [1] Sepsis-like cytokine release syndrome after application of tebentafusp in metastasized uveal melanoma
    Geidel, G.
    Abeck, F.
    Hansen, I.
    Koett, J.
    Heidrich, I.
    Ruenger, A.
    Reschke, R.
    Hildebrandt, L.
    Gebhardt, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 81 - 82
  • [2] Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in previously untreated patients with metastatic uveal melanoma
    Salama, A. K. S.
    Cheshuk, V.
    Siveke, J.
    Berrocal, A.
    Abdullah, S. E.
    Lockwood, S.
    McCully, M. L.
    Kee, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S855 - S855
  • [3] Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report
    Lazaro Sanchez, Antonio David
    Benitez Fuentes, Javier David
    Luengo Gil, Gines
    Garcia Garcia, Maria Teresa
    Feliciangeli Moreno, Eduardo
    Conesa Zamora, Pablo
    Balsalobre Yago, Jose
    Mohamed Mohamed, Kauzar
    Arroyo Rodriguez, Ana Belen
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [4] MORE THAN MEETS THE EYE: LIFE-THREATENING CYTOKINE RELEASE SYNDROME FOLLOWING METASTATIC UVEAL MELANOMA TREATMENT WITH TEBENTAFUSP
    Fisher, Emma
    Chow, Stacy
    CHEST, 2024, 166 (04) : 1789A - 1790A
  • [5] Cytokine Profiles in Human Parechovirus Type 3-induced Sepsis-like Syndrome
    Shimizu, Masaki
    Shimizu, Hiroyuki
    Jinkawa, Asumi
    Yamamiya, Mari
    Shinozaki, Eri
    Yokoyama, Tadafumi
    Ohta, Kazuhide
    Sakumura, Naoto
    Takakuwa, Maiko
    Fujita, Shuhei
    Fusagawa, Shintaro
    Nakagishi, Yasuo
    Nariai, Eri
    Yachie, Akihiro
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (02) : 137 - 139
  • [6] Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-Like" syndrome
    Adrie, C
    Adib-Conquy, M
    Laurent, I
    Monchi, M
    Vinsonneau, C
    Fitting, C
    Fraisse, F
    Dinh-Xuan, AT
    Carli, P
    Spaulding, C
    Dhainaut, JF
    Cavaillon, JM
    CIRCULATION, 2002, 106 (05) : 562 - 568
  • [7] Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in patients (pts) with previously treated (2L+) metastatic uveal melanoma (mUM).
    Carvajal, Richard D.
    Sato, Takami
    Butler, Marcus O.
    Sacco, Joseph J.
    Shoushtari, Alexander Noor
    Hassel, Jessica Cecile
    Ikeguchi, Alexandra
    Hernandez-Aya, Leonel Fernando
    Rioth, Matthew
    Hamid, Omid
    Piulats, Josep M.
    Luke, Jason J.
    Buckner Johnson, Douglas
    Leyvraz, Serge
    Espinosa, Enrique
    Collins, Laura
    McCully, Michelle L.
    Lockwood, Sarah
    Abdullah, Shaad Essa
    Nathan, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Natural cannabinoids suppress the cytokine storm in sepsis-like in vitro model
    Yishay Szekely
    Merav Ingbir
    Ohad S. Bentur
    Ohad Hochner
    Reuven Porat
    European Cytokine Network, 2020, 31 : 50 - 58
  • [9] Ascorbic acid attenuates activation and cytokine production in sepsis-like monocytes
    Schmidt, Tobias
    Kahn, Robin
    Kahn, Fredrik
    JOURNAL OF LEUKOCYTE BIOLOGY, 2022, 112 (03) : 491 - 498
  • [10] Successful therapy of a metastatic uveal melanoma with tebentafusp after prior immunotherapy with ipilimumab and nivolumab
    Haalck, T.
    Burg, M. R.
    Heidrich, I.
    Heilberger, J.
    Hildebrandt, L.
    Kott, J.
    Wiltfang, L.
    Gebhardt, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 59 - 59
12345